|
ZNF792 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.237800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.764400E-02 |
| Normal-vs-Stage2 |
3.989400E-01 |
| Normal-vs-Stage3 |
2.668200E-01 |
| Normal-vs-Stage4 |
2.144800E-01 |
| Stage1-vs-Stage2 |
4.938200E-01 |
| Stage1-vs-Stage3 |
4.139200E-01 |
| Stage1-vs-Stage4 |
8.076200E-01 |
| Stage2-vs-Stage3 |
9.349800E-01 |
| Stage2-vs-Stage4 |
7.139200E-01 |
| Stage3-vs-Stage4 |
7.250000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.355450E-01 |
| Normal-vs-AfricanAmerican |
4.581900E-02 |
| Normal-vs-Asian |
1.018370E-01 |
| Caucasian-vs-AfricanAmerican |
1.438240E-01 |
| Caucasian-vs-Asian |
3.675200E-01 |
| AfricanAmerican-vs-Asian |
5.503800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.963600E-02 |
| Normal-vs-Female |
1.758850E-01 |
| Male-vs-Female |
1.094430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.070100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.374210E-01 |
| Normal-vs-Age(61-80Yrs) |
2.618400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.439600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.967200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.117400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.156800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.043000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.272800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.153000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.708200E-01 |
| Classical-VS-Follicular |
1.764260E-02 |
| Classical-VS-Other |
2.808600E-01 |
| Classical-VS-Normal |
1.878200E-02 |
| Tall-VS-Follicular |
6.245800E-01 |
| Tall-VS-Other |
7.094000E-01 |
| Tall-VS-Normal |
4.453000E-01 |
| Follicular-VS-Other |
7.981400E-01 |
| Follicular-VS-Normal |
7.145000E-01 |
| Other-VS-Normal |
9.341400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.392010E-01 |
| Normal-vs-N1 |
9.409600E-01 |
| N0-vs-N1 |
1.555570E-01 |
|
|
